FOS and myelodysplastic syndrome: As shown in Figure 5A, the increase of nascent FOS mRNA by emetine treatment for 30 min was 2.2±0.1-fold in MDS granulocytes, which was not significantly different from that in the control cells (2.4±0.3-fold).